kabutan

Linical Co., Ltd.(2183) Summary

2183
TSE Standard
Linical Co., Ltd.
301
JPY
-1
(-0.33%)
Dec 5, 12:34 pm JST
1.94
USD
Dec 4, 10:34 pm EST
Result
PTS
outside of trading hours
301.3
Dec 5, 12:45 pm JST
Summary Chart Historical News Financial Result
PER
PBR
1.12
Yield
5.32%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
303 JPY 1.95 USD
Previous Close Dec 4
302 JPY 1.94 USD
High Dec 5, 9:00 am
303 JPY 1.95 USD
Low Dec 5, 9:16 am
301 JPY 1.93 USD
Volume
19,000
Trading Value
6.00M JPY 0.04M USD
VWAP
301.94 JPY 1.95 USD
Minimum Trading Value
30,100 JPY 194 USD
Market Cap
7.45B JPY 0.05B USD
Number of Trades
33
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
55
1-Year High Jan 30, 2025
296
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 0 155,400
Nov 21, 2025 0 102,600
Nov 14, 2025 0 150,200
Nov 7, 2025 0 103,600
Oct 31, 2025 0 100,800
Company Profile
Linical Co., Ltd. specializes in contract research for pharmaceutical development, focusing on Phase II and III clinical trials. The company also provides support for pharmaceutical sales.
Sector
Services
Linical Co., Ltd. primarily engages in Contract Research Organization (CRO) services for pharmaceutical development, while also offering post-marketing support services for pharmaceuticals. In its CRO business, the company undertakes various tasks including clinical trial monitoring, quality control, data management, statistical analysis, and medical writing for documents such as clinical trial protocols. Additionally, Linical provides drug discovery support services, offering consulting on development strategy planning, regulatory affairs, and approval applications for biotech venture companies. In its post-marketing support business, Linical handles planning, monitoring, and auditing services. Through these operations, Linical offers comprehensive global services spanning from drug discovery support to clinical development, and post-approval lifecycle management, including post-marketing clinical trials and research.